DeMuth Peter
SEC CIK 1979163 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| ELTX | Elicio Therapeutics, Inc. | CSO | 21.5K | — | — | 3 | 2024-12-16 | 2026-02-02 |
Most active insiders at ELTX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeMuth Peter | CSO | — | — |
| 2 | Connelly Robert | CEO, Pres, Dir | — | — |
| 3 | Shah Preetam | See Remarks | — | — |
| 4 | Haqq Christopher | See Remarks | — | — |
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-02-03 | 2026-02-02 | ELTX | Elicio Therapeutics, Inc. | DeMuth Peter | CSO | A - Grant | $0.00 | +20.8K | 21.5K | +2,799% | $0 |
| D | 2025-12-10 | 2025-12-09 | ELTX | Elicio Therapeutics, Inc. | DeMuth Peter | CSO | M - OptEx | $4.41 | +362 | 743 | +95% | +$1,596 |
| D | 2024-12-18 | 2024-12-16 | ELTX | Elicio Therapeutics, Inc. | DeMuth Peter | CSO | M - OptEx | $4.41 | +381 | 381 | New | +$1,680 |
Purchase Sale Sale after option exercise All abbreviations